Isomorphic Labs Raises $5B for Drug Discovery Using AI Models
Confirmed
Confidence
90%
Impact: 80%
Updated 1d agoConsensus Brief
Isomorphic Labs, an AI drug-discovery platform spun out of Google’s DeepMind, has raised $5 billion in a Series C funding round to advance its drug candidates to clinical trials. The funding was co-led by Greenoaks and Sequoia Capital, with participation from Andreessen Horowitz and existing investors including Alphabet's GV and Capital G. The company has reported positive preclinical results in oncology and immunology and aims to expand its drug-design engine.
What Changed Since Last Update
1d ago
New corroborating source added: TechCrunch published an update on Tue, 17 No ("Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials").
Claim Ledger
3 claims tracked across sources
Role-Based Impact Analysis
Source Timeline
11 sources corroborating
T2
T2
T2
T2
T2
T2
T2
T2
T2